Affordable Access

deepdyve-link
Publisher Website

Role of Cardiac Imaging Modalities in the Evaluation of COVID-19-Related Cardiomyopathy.

Authors
  • Cecchetto, Antonella1
  • Nistri, Stefano2
  • Baroni, Giulia1
  • Torreggiani, Gianpaolo1
  • Aruta, Patrizia1
  • Pergola, Valeria1
  • Baritussio, Anna1
  • Previtero, Marco1
  • Palermo, Chiara1
  • Iliceto, Sabino1
  • Mele, Donato1
  • 1 Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, 35128 Padova, Italy. , (Italy)
  • 2 Department of Cardiology, CMSR, Altavilla Vicentina, 36077 Vicenza, Italy. , (Italy)
Type
Published Article
Journal
Diagnostics
Publisher
MDPI AG
Publication Date
Apr 04, 2022
Volume
12
Issue
4
Identifiers
DOI: 10.3390/diagnostics12040896
PMID: 35453944
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Cardiac involvement has been described during the course of SARS-CoV-2 disease (COVID-19), with different manifestations. Several series have reported only increased cardiac troponin without ventricular dysfunction, others the acute development of left or right ventricular dysfunction, and others myocarditis. Ventricular dysfunction can be of varying degrees and may recover completely in some cases. Generally, conventional echocardiography is used as a first approach to evaluate cardiac dysfunction in patients with COVID-19, but, in some cases, this approach may be silent and more advanced cardiac imaging techniques, such as myocardial strain imaging or cardiac magnetic resonance, are necessary to document alterations in cardiac structure or function. In this review we sought to discuss the information provided by different cardiac imaging techniques in patients with COVID-19, both in the acute phase of the disease and after discharge from hospital, and their diagnostic and prognostic role. We also aimed at verifying whether a specific form of cardiac disease due to the SARS-CoV-2 can be identified.

Report this publication

Statistics

Seen <100 times